[go: up one dir, main page]

ITMI962628A0 - Composizione farmaceutica - Google Patents

Composizione farmaceutica

Info

Publication number
ITMI962628A0
ITMI962628A0 IT96MI002628A ITMI962628A ITMI962628A0 IT MI962628 A0 ITMI962628 A0 IT MI962628A0 IT 96MI002628 A IT96MI002628 A IT 96MI002628A IT MI962628 A ITMI962628 A IT MI962628A IT MI962628 A0 ITMI962628 A0 IT MI962628A0
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
IT96MI002628A
Other languages
English (en)
Inventor
Giorgio Fassina
Falco Sandro De
Original Assignee
Tecnogen Scpa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnogen Scpa filed Critical Tecnogen Scpa
Priority to IT96MI002628A priority Critical patent/ITMI962628A1/it
Publication of ITMI962628A0 publication Critical patent/ITMI962628A0/it
Priority to ES97954430T priority patent/ES2183237T3/es
Priority to US09/319,273 priority patent/US6426401B1/en
Priority to JP52733798A priority patent/JP4071830B2/ja
Priority to CA002275213A priority patent/CA2275213A1/en
Priority to KR10-1999-7005432A priority patent/KR100502074B1/ko
Priority to EA199900551A priority patent/EA001468B1/ru
Priority to AT97954430T priority patent/ATE224724T1/de
Priority to DE69715910T priority patent/DE69715910T2/de
Priority to PCT/EP1997/007143 priority patent/WO1998026794A1/en
Priority to AU58583/98A priority patent/AU5858398A/en
Priority to CN971806942A priority patent/CN1216637C/zh
Priority to EP97954430A priority patent/EP0948345B1/en
Publication of ITMI962628A1 publication Critical patent/ITMI962628A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT96MI002628A 1996-12-16 1996-12-16 Composizione farmaceutica ITMI962628A1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT96MI002628A ITMI962628A1 (it) 1996-12-16 1996-12-16 Composizione farmaceutica
EP97954430A EP0948345B1 (en) 1996-12-16 1997-12-11 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
EA199900551A EA001468B1 (ru) 1996-12-16 1997-12-11 Фармацевтическая композиция, содержащая ингибитор иммуноглобулин-рецепторного взаимодействия
US09/319,273 US6426401B1 (en) 1996-12-16 1997-12-11 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
JP52733798A JP4071830B2 (ja) 1996-12-16 1997-12-11 免疫グロブリン受容体相互作用の阻害剤を含んでいる医薬組成物
CA002275213A CA2275213A1 (en) 1996-12-16 1997-12-11 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
KR10-1999-7005432A KR100502074B1 (ko) 1996-12-16 1997-12-11 면역글로블린-수용기의 상호 작용의 억제제를 함유하고 있는 약학 조성물
ES97954430T ES2183237T3 (es) 1996-12-16 1997-12-11 Composicion farmaceutica que contiene un inhibidor de la interaccion inmunoglobulina-receptor.
AT97954430T ATE224724T1 (de) 1996-12-16 1997-12-11 Pharmazeutische zusammensetzung enthaltend peptide für die inhibierung der immunoglobulin- rezeptor interaktion
DE69715910T DE69715910T2 (de) 1996-12-16 1997-12-11 Pharmazeutische zusammensetzung enthaltend peptide für die inhibierung der immunoglobulin-rezeptor interaktion
PCT/EP1997/007143 WO1998026794A1 (en) 1996-12-16 1997-12-11 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
AU58583/98A AU5858398A (en) 1996-12-16 1997-12-11 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
CN971806942A CN1216637C (zh) 1996-12-16 1997-12-11 包含免疫球蛋白－受体相互作用的抑制剂的药物组合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI002628A ITMI962628A1 (it) 1996-12-16 1996-12-16 Composizione farmaceutica

Publications (2)

Publication Number Publication Date
ITMI962628A0 true ITMI962628A0 (it) 1996-12-16
ITMI962628A1 ITMI962628A1 (it) 1998-06-16

Family

ID=11375401

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI002628A ITMI962628A1 (it) 1996-12-16 1996-12-16 Composizione farmaceutica

Country Status (13)

Country Link
US (1) US6426401B1 (it)
EP (1) EP0948345B1 (it)
JP (1) JP4071830B2 (it)
KR (1) KR100502074B1 (it)
CN (1) CN1216637C (it)
AT (1) ATE224724T1 (it)
AU (1) AU5858398A (it)
CA (1) CA2275213A1 (it)
DE (1) DE69715910T2 (it)
EA (1) EA001468B1 (it)
ES (1) ES2183237T3 (it)
IT (1) ITMI962628A1 (it)
WO (1) WO1998026794A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6916904B2 (en) 2002-04-24 2005-07-12 Zolaris Biosciences, Llc Inhibition of immune complex formation
AU2005221187B2 (en) 2004-03-10 2011-09-01 Trinity Therapeutics, Inc. Method for inhibiting immune complex formation in a subjetc
ITMI20071119A1 (it) 2007-06-01 2008-12-02 Tecnogen Spa Nuovi ligandi sintetici per immunoglobuline e composizioni farmaceutiche che li comprendono
SG10201500597YA (en) 2008-07-18 2015-04-29 Trinity Therapeutics Inc Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome
US10591480B2 (en) 2016-06-06 2020-03-17 Medizinische Universität Wien Method for the detection of an IgM antibody specific for a flavivirus in a sample

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA846192B (en) * 1984-08-09 1986-03-26 Merck Patent Gmbh Immunotherapeutic polypeptide agents
EP0190127A1 (en) * 1984-08-10 1986-08-13 MERCK PATENT GmbH Immunotherapeutic polypeptide agents
FR2655269B1 (fr) * 1989-12-01 1994-02-11 Curie Universite Pierre Marie Proteines empechant l'interaction entre un fragment fc d'une immunoglobuline et son recepteur et utilisation en therapeutique, notamment dans le traitement des affections liees aux virus hiv.
AU3002695A (en) * 1994-07-08 1996-02-09 King's College Ige antagonists
EP0752425B1 (en) * 1995-06-21 1999-09-29 TECNOGEN Società Consortile per azioni Peptide ligands for the constant region of immunoglobulins

Also Published As

Publication number Publication date
EP0948345A1 (en) 1999-10-13
US6426401B1 (en) 2002-07-30
CA2275213A1 (en) 1998-06-25
WO1998026794A1 (en) 1998-06-25
DE69715910D1 (de) 2002-10-31
ITMI962628A1 (it) 1998-06-16
KR100502074B1 (ko) 2005-07-25
ES2183237T3 (es) 2003-03-16
JP4071830B2 (ja) 2008-04-02
KR20000057634A (ko) 2000-09-25
CN1216637C (zh) 2005-08-31
EP0948345B1 (en) 2002-09-25
EA001468B1 (ru) 2001-04-23
CN1240357A (zh) 2000-01-05
EA199900551A1 (ru) 2000-02-28
AU5858398A (en) 1998-07-15
ATE224724T1 (de) 2002-10-15
JP2001506994A (ja) 2001-05-29
DE69715910T2 (de) 2003-05-22

Similar Documents

Publication Publication Date Title
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
ID18352A (id) Komposisi-komposisi farmasi
NO20004345D0 (no) Farmasøytisk sammensetning
FI20071025L (fi) Farmaseuttisia koostumuksia
FI991302A7 (fi) Parannetut farmaseuttiset koostumukset
ID17774A (id) Komposisi farmasi antitrombosis
BR9507768A (pt) Composição farmacêutica
ID29294A (id) Komposisi farmasi
LV11727A (lv) Farmaceitiska kompozicija
FI973229A0 (fi) Uusi farmaseuttinen koostumus
ID18698A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
FI973280A0 (fi) Farmaseuttinen koostumus
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI961364L (fi) Lääkeainekoostumus
ITMI962628A0 (it) Composizione farmaceutica
BR9605777A (pt) Composição farmacêutica
FI962738A0 (fi) Farmaseuttiset koostumukset
FI954050A7 (fi) Lääkekoostumuksia
ID23531A (id) Komposisi farmasi
NO964309D0 (no) Farmasöytisk sammensetning
ID17133A (id) Komposisi farmasi
SE9604299D0 (sv) Pharmaceutical composition
SE9601854D0 (sv) Farmaceutisk komposition
SE9402924D0 (sv) Novel pharmaceutical composition